StockData
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Nexalin Technology, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.36+0.01 (+0.43%)

Close on Oct 19, 2026

Market cap
$49.90M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Nexalin Technology has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Nexalin Technology filed with the SEC